INTERVENTIONAL CARDIOLOGY
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
Development and initial validation
Roxana Mehran, MD*, ,
Eve D. Aymong, MD, MSc, FACC*,
Eugenia Nikolsky, MD, PhD*,,
Zoran Lasic, MD, FACC*,
Ioannis Iakovou, MD*,
Martin Fahy, MSc*,
Gary S. Mintz, MD, FACC*,
Alexandra J. Lansky, MD, FACC*,,
Jeffrey W. Moses, MD, FACC*,,
Gregg W. Stone, MD, FACC*,,
Martin B. Leon, MD, FACC*, and
George Dangas, MD, PhD, FACC*,,*
* Cardiovascular Research Foundation
Columbia University Medical Center, New York, New York
Manuscript received February 4, 2004;
revised manuscript received June 14, 2004,
accepted June 22, 2004.
* Reprint requests and correspondence: Dr. George Dangas, Columbia University Medical Center, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10022 (Email: gdangas{at}crf.org).
OBJECTIVES: We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
BACKGROUND: Although several risk factors for CIN have been identified, the cumulative risk rendered by their combination is unknown.
METHODS: A total of 8,357 patients were randomly assigned to a development and a validation dataset. The baseline clinical and procedural characteristics of the 5,571 patients in the development dataset were considered as candidate univariate predictors of CIN (increase  25% and/or 0.5 mg/dl in serum creatinine at 48 h after PCI vs. baseline). Multivariate logistic regression was then used to identify independent predictors of CIN with a p value <0.0001. Based on the odds ratio, eight identified variables (hypotension, intra-aortic balloon pump, congestive heart failure, chronic kidney disease, diabetes, age >75 years, anemia, and volume of contrast) were assigned a weighted integer; the sum of the integers was a total risk score for each patient.
RESULTS: The overall occurrence of CIN in the development set was 13.1% (range 7.5% to 57.3% for a low [ 5] and high [16] risk score, respectively); the rate of CIN increased exponentially with increasing risk score (Cochran Armitage chi-square, p < 0.0001). In the 2,786 patients of the validation dataset, the model demonstrated good discriminative power (c statistic = 0.67); the increasing risk score was again strongly associated with CIN (range 8.4% to 55.9% for a low and high risk score, respectively).
CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes.
|
Abbreviations and Acronyms
| | CIN = contrast-induced nephropathy | | eGFR = estimated glomerular filtration rate | | IABP = intra-aortic balloon pump | | OR = odds ratio | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:
|
|
|
|
 
K. Spargias, E. Adreanides, E. Demerouti, A. Gkouziouta, A. Manginas, G. Pavlides, V. Voudris, and D. V. Cokkinos
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Circulation,
November 3, 2009;
120(18):
1793 - 1799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Wessely, T. Koppara, C. Bradaric, M. Vorpahl, S. Braun, S. Schulz, J. Mehilli, A. Schomig, A. Kastrati, and for the Contrast Media and Nephrotoxicity Followin
Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention
Circ Cardiovasc Interv,
October 1, 2009;
2(5):
430 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Brar, S. Hiremath, G. Dangas, R. Mehran, S. K. Brar, and M. B. Leon
Sodium Bicarbonate for the Prevention of Contrast Induced-Acute Kidney Injury: A Systematic Review and Meta-analysis
Clin. J. Am. Soc. Nephrol.,
October 1, 2009;
4(10):
1584 - 1592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mehran, E. Nikolsky, A. J. Kirtane, A. Caixeta, S. C. Wong, P. S. Teirstein, W. E. Downey, W. B. Batchelor, P. J. Casterella, Y.-H. Kim, et al.
Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients: The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study
J. Am. Coll. Cardiol. Intv.,
May 1, 2009;
2(5):
415 - 421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Meyer, M. M. LeWinter, S. P. Bell, Z. Chen, D. E. Selby, D. K. Singla, and H. L. Dauerman
N-Acetylcysteine-Enhanced Contrast Provides Cardiorenal Protection
J. Am. Coll. Cardiol. Intv.,
March 1, 2009;
2(3):
215 - 221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Waikar and J. V. Bonventre
Creatinine Kinetics and the Definition of Acute Kidney Injury
J. Am. Soc. Nephrol.,
March 1, 2009;
20(3):
672 - 679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Marenzi, E. Assanelli, J. Campodonico, G. Lauri, I. Marana, M. De Metrio, M. Moltrasio, M. Grazi, M. Rubino, F. Veglia, et al.
Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality
Ann Intern Med,
February 3, 2009;
150(3):
170 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Goldfarb, P. A. McCullough, J. McDermott, and S. B. Gay
Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology
Mayo Clin. Proc.,
February 1, 2009;
84(2):
170 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Brar, A. Y.-J. Shen, M. B. Jorgensen, A. Kotlewski, V. J. Aharonian, N. Desai, M. Ree, A. I. Shah, and R. J. Burchette
Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial
JAMA,
September 3, 2008;
300(9):
1038 - 1046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maioli, A. Toso, M. Leoncini, M. Gallopin, D. Tedeschi, C. Micheletti, and F. Bellandi
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
J. Am. Coll. Cardiol.,
August 19, 2008;
52(8):
599 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Baumgarten and J. H. Ellis
Contrast-Induced Nephropathy: Contrast Material Not Required?
Am. J. Roentgenol.,
August 1, 2008;
191(2):
383 - 386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Kuhn, N. Chen, D. V. Sahani, D. Reimer, E. J. R. van Beek, J. P. Heiken, and G. J. So
The PREDICT Study: A Randomized Double-Blind Comparison of Contrast-Induced Nephropathy After Low- or Isoosmolar Contrast Agent Exposure
Am. J. Roentgenol.,
July 1, 2008;
191(1):
151 - 157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mockel, M. Radovic, Y. Kuhnle, V. Combe, J. Waigand, S. Schroder, R. Dietz, U. Frei, and K.-U. Eckardt
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography
Nephrol. Dial. Transplant.,
May 1, 2008;
23(5):
1588 - 1594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Waikar, K. D. Liu, and G. M. Chertow
Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol.,
May 1, 2008;
3(3):
844 - 861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. McCullough
Contrast-Induced Acute Kidney Injury
J. Am. Coll. Cardiol.,
April 15, 2008;
51(15):
1419 - 1428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Kane, B. J. Doyle, A. Lerman, G. W. Barsness, P. J. Best, and C. S. Rihal
Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
J. Am. Coll. Cardiol.,
January 1, 2008;
51(1):
89 - 90.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult,
January 1, 2008;
3(2008):
573 - 598.
[Full Text]
|
|
|
|
|
|
|
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance
Vascular Medicine,
November 1, 2007;
12(4):
359 - 378.
[PDF]
|
|
|
|
|
|
|
G. T. C. Wong and M. G. Irwin
Contrast-induced nephropathy
Br. J. Anaesth.,
October 1, 2007;
99(4):
474 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Waikar, G. C. Curhan, J. Z. Ayanian, and G. M. Chertow
Race and Mortality after Acute Renal Failure
J. Am. Soc. Nephrol.,
October 1, 2007;
18(10):
2740 - 2748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology
J. Am. Coll. Cardiol.,
September 11, 2007;
50(11):
1097 - 1114.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. K. Laskey, C. Jenkins, F. Selzer, O. C. Marroquin, R. L. Wilensky, R. Glaser, H. A. Cohen, D. R. Holmes Jr, and for the NHLBI Dynamic Registry Investigators
Volume-to-Creatinine Clearance Ratio: A Pharmacokinetically Based Risk Factor for Prediction of Early Creatinine Increase After Percutaneous Coronary Intervention
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
584 - 590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. King III, T. Aversano, W. L. Ballard, R. H. Beekman III, M. J. Cowley, S. G. Ellis, D. P. Faxon, E. L. Hannan, J. W. Hirshfeld Jr, A. K. Jacobs, et al.
ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures)
J. Am. Coll. Cardiol.,
July 3, 2007;
50(1):
82 - 108.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Solomon
Contrast media nephropathy--how to diagnose and how to prevent?
Nephrol. Dial. Transplant.,
July 1, 2007;
22(7):
1812 - 1815.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Eur. Heart J.,
July 1, 2007;
28(13):
1598 - 1660.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Deray
Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
J. Am. Coll. Cardiol.,
April 17, 2007;
49(15):
1668 - 1668.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Jo, B.-K. Koo, T.-J. Youn, and H.-S. Kim
Reply.
J. Am. Coll. Cardiol.,
April 17, 2007;
49(15):
1669 - 1670.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Briguori, F. Airoldi, D. D'Andrea, E. Bonizzoni, N. Morici, A. Focaccio, I. Michev, M. Montorfano, M. Carlino, J. Cosgrave, et al.
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies
Circulation,
March 13, 2007;
115(10):
1211 - 1217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Mathew, K Haque, and W Woothipoom
Acute renal failure induced by contrast medium: steps towards prevention.
BMJ,
September 9, 2006;
333(7567):
539 - 540.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Jo, T.-J. Youn, B.-K. Koo, J.-S. Park, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, G.-W. Joo, I.-H. Chae, D.-J. Choi, et al.
Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study: A Randomized Controlled Trial
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
924 - 930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network
Prophylaxis Strategies for Contrast-Induced Nephropathy
JAMA,
June 21, 2006;
295(23):
2765 - 2779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J.,
June 1, 2006;
27(11):
1341 - 1381.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A D Grayson, R K Moore, M Jackson, S Rathore, S Sastry, T P Gray, I Schofield, A Chauhan, F F Ordoubadi, B Prendergast, et al.
Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England
Heart,
May 1, 2006;
92(5):
658 - 663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tepel, P. Aspelin, and N. Lameire
Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach
Circulation,
April 11, 2006;
113(14):
1799 - 1806.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Barrett and P. S. Parfrey
Preventing Nephropathy Induced by Contrast Medium
N. Engl. J. Med.,
January 26, 2006;
354(4):
379 - 386.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Brinker, C. J. Davidson, and W. Laskey
Preventing in-hospital cardiac and renal complications in high-risk PCI patients
Eur. Heart J. Suppl.,
August 1, 2005;
7(suppl_G):
G13 - G24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and S. Matetzky
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies
Can. Med. Assoc. J.,
May 24, 2005;
172(11):
1461 - 1471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, et al.
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
JAMA,
May 4, 2005;
293(17):
2126 - 2130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. W. O'Neill, S. R. Dixon, and C. L. Grines
The year in interventional cardiology
J. Am. Coll. Cardiol.,
April 5, 2005;
45(7):
1117 - 1134.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Prediction Rule for Post-PCI Contrast Nephropathy
Journal Watch Dermatology,
December 29, 2004;
2004(1229):
8 - 8.
[Full Text]
|
|
|
|
|
|
|
Prediction Rule for Post-PCI Contrast Nephropathy
Journal Watch (General),
November 19, 2004;
2004(1119):
2 - 2.
[Full Text]
|
|
|
|
